For Phase 1, judges reviewed submitted concepts and plans for development of innovative diagnostics. Judges selected 10 winners to move on to the Phase 2 virtual accelerator.
At the conclusion of Phase 2, judges will review each team’s refined concepts and plans for development. Judges will recommend teams to advance to the next phase based on the official evaluation criteria.
When evaluating final submissions for each phase, the judging panel assigns each submission 1 to 5 (5 being the highest; 1 being the lowest) points for each of the phase criteria, for a maximum of 35 points.
Learn more about the judging panel and their role in supporting the LymeX Diagnostics Prize below.